Claire Marie Porter is a reporter with The Cancer Letter. She joined the publication in 2024.

Before joining The Cancer Letter, Claire was a freelance health and science journalist with bylines in The Atlantic, Scientific American, The Washington Post, Undark Magazine, Popular Science, WIRED among other publications. She graduated with an M.S. in Journalism from Columbia University in 2020, where she received honors for her thesis "The Deadly Itch" on Intrahepatic Cholestasis of pregnancy.

She was a 2020 Society of Environmental Journalists grant recipient, and completed internships with Next City and National Public Radio.

She graduated from Temple University with a Bachelor’s degree in English in 2013.
Latest Stories
Trump’s tariffs will likely affect cancer drugs and devices—and may deepen drug shortages
News Analysis
For over a month since President Trump announced his intent to impose aggressive new tariffs on America’s friends and foes alike, lobbyists for hospitals, medical societies, and makers of branded and generic drugs have been trying to convince him to rethink. 
Trump et al. focus on NIH, cancer—and how peer review is done
Regulatory News
In a speech before a joint session of Congress, President Trump briefly addressed pediatric cancer, pointing to a 13-year old brain tumor survivor, Devarjaye “DJ” Daniel, who was watching from the gallery, making his dream come true by naming him a Secret Service agent. 
Survey reveals most Americans are uninformed about HPV A vaccine can prevent cancer—most people don’t take it
Clinical
Each year, nearly 14 million people in the U.S. contract human papillomavirus, a common, sexually-transmitted virus that can cause several cancers.
Fired NCI employee says Trump’s purge was baseless yet punitive “I feel like I’ve been erased”
White House
On the evening of Feb. 15, when the dreaded letter of termination arrived, an NCI employee was just a few weeks away from job security—the end of the probationary period. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login